Incyte (INCY) Long-Term Investments (2014 - 2026)
Incyte (INCY) posted Long-Term Investments of $54.6 million for Q1 2026, up 13.73% on a QoQ basis from $48.0 million in Q4 2025, and up 212.56% year-over-year from $17.5 million in Q1 2025.
Incyte (INCY) Long-Term Investments (2014 - 2026) Analysis & Trends
Incyte's Long-Term Investments history runs 13 years deep, the most recent figure standing at $54.6 million for Q1 2026.
- Quarterly Long-Term Investments rose 212.56% year-over-year to $54.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.6 million (up 212.56% YoY) and the FY2025 annual result came in at $48.0 million, up 155.08% from the prior year.
- Long-Term Investments was $54.6 million for Q1 2026 at Incyte, up from $48.0 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $287.7 million in Q1 2024 and bottomed at $1.6 million in Q3 2022.
- A 5-year average of $76.3 million and a median of $29.7 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments sank 99.26% — and 2023, when it surged 10259.85%.
- Incyte's Long-Term Investments stood at $133.7 million in 2022, then jumped by 40.43% to $187.7 million in 2023, then plunged by 89.98% to $18.8 million in 2024, then jumped by 155.08% to $48.0 million in 2025, then advanced by 13.73% to $54.6 million in 2026.
- Business Quant data shows INCY's Long-Term Investments at $54.6 million in Q1 2026, $48.0 million in Q4 2025, and $21.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 54.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.58 Mn |
| Dec 31, 2025 | 47.99 Mn |
| Sep 30, 2025 | 21.87 Mn |
| Jun 30, 2025 | 13.31 Mn |
| Mar 31, 2025 | 17.46 Mn |
| Dec 31, 2024 | 18.81 Mn |
| Sep 30, 2024 | 27.57 Mn |
| Jun 30, 2024 | 29.67 Mn |
| Mar 31, 2024 | 287.66 Mn |
| Dec 31, 2023 | 187.72 Mn |
| Sep 30, 2023 | 153.66 Mn |
| Jun 30, 2023 | 170.32 Mn |
| Mar 31, 2023 | 128.31 Mn |
| Dec 31, 2022 | 133.68 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.64 Mn |
| Mar 31, 2022 | 1.70 Mn |
| Dec 31, 2021 | 221.27 Mn |
| Sep 30, 2021 | 192.10 Mn |
| Jun 30, 2021 | 220.69 Mn |